Exposures nearly doubled from 460 the quarter before, and the FDA got two death reports it hasn't verified. Lilly says it has referred over 200 sellers to regulators.
Recap by typeshit. Full story at Medical Daily.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Parliamentary data shows 104 NAION cases and thousands treated for gallstones, though it doesn't prove the drugs caused them. Doctors left 97% of flagged scripts unchanged.
Another short teaser from the Medical Update interview series, this one on the pace of weight loss with GLP-1 drugs. The full episode is on Spotify.
Loading…